The Right Place at the Right Time – A Personal StoryAngie Godinez
I marvel sometimes at the confluence of forces that brought me to where I am today – co-founder of Bioscience Americas and participant in my company’s efforts to be a leading provider of innovative and life enhancing healthcare therapies.
It was a little more than two years ago that I teamed with Eric Stoffers and Tim Kopatich to create Bioscience Americas. Through contacts we nurtured, we were able to meet and get to know a group of biomedical scientists renowned throughout the scientific community, indeed throughout the world, for their ground-breaking work in the field of autologous stem cell research. Fifteen years ago these scientists assembled a world-wide research consortium that became the Global Institute of Stem Cell Therapy and Research, or GIOSTAR.
As experienced executives and venture capital professionals, Eric, Tim and I were asked by GIOSTAR’s founder Dr. Anand Srivastava, to work with them to bring the science out of the lab and into the marketplace. Using GIOSTAR’s success in treating more than 4,000 patients in India, Dr. Srivastava’s vision was, and is, to help patients throughout the world suffering from serious autoimmune diseases. That’s where we entered the picture. GIOSTAR provides the scientific knowledge and continued research and Bioscience Americas and our investors provide the capital to build and operate our joint venture clinics.
I mentioned at the start of this blog that I marvel at the forces of fate that brought all of this together. I also marvel at my incredible luck in being in the right place at the right time.
As good fortune would have it, Tim Kopatich’s wife is from Colombia. Because of this, Tim has had the opportunity to travel to that beautiful country many times. As an experienced Latin American real estate developer, he was able to join up with U.S. based developer Nestor Limas to create luxury condo and hotel projects in Medellin. Through their local Colombian relationships, we secured our association with Hospital in Rio Negro, Colombia. is the pre-eminent organ transplant hospital in South America and treats close to 50,000 patients every year. This relationship represents a significant revenue source for our investors in addition to our medical tourism success. All the pieces of this magnificent puzzle are falling into place and very soon we will be treating our first stem cell patient at . We have begun to explore additional clinic opportunities in Brazil, Chile, Costa Rica, Mexico, and on Native American tribal land within the U.S. When you’ve created a better mouse trap, the world truly does beat a path to your door.
As a retired CPA, I instinctively recognized the value of GIOSTAR’s more than $400 million in research and what that means to our patients and investors. We’ve successfully harnessed this research to deliver the treatments and therapy protocols to our patients and we’ve successfully positioned Bioscience Americas to deliver handsome returns to our investors.
So this lucky number cruncher finds himself in the unlikely position of being an instrument in the evolving paradigm shift taking place in medicine. We offer hope where none existed, health when it wasn’t expected, and renewed life to be lived to the fullest by our patients.
I’m glad to be where I am today.